Drug
Cocaine (IV)
Cocaine (IV) is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
75%
Ph early_phase_1
1
25%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Early Phase 11 (25.0%)
Phase 13 (75.0%)
Trials by Status
unknown250%
completed125%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingearly_phase_1
Cocaine and Pentoxifylline (BED IN 47)
NCT07086794
completedphase_1
A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine
NCT02856854
unknownphase_1
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066
unknownphase_1
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315
Clinical Trials (4)
Showing 4 of 4 trials
NCT07086794Early Phase 1
Cocaine and Pentoxifylline (BED IN 47)
NCT02856854Phase 1
A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine
NCT00040066Phase 1
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00094315Phase 1
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4